Correction: p38 MAP Kinase Links CAR Activation and Inactivation in the Nucleus via Phosphorylation at Threonine 38 s (Drug Metabolism and Disposition (2016) 44 (871-876) DOI: 10.1124/DMD.116.070235);P38 MAP Kinase links CAR activation and inactivation in the nucleus via phosphorylation at threonine 38

Drug Metabolism and Disposition

Volumn 44, Issue 6, 2016, Pages 871-876

  Hori, Takeshi ^a   Moore, Rick ^a   Negishi, Masahiko ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 2B; CYTOCHROME P450 2B6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; RETINOID X RECEPTOR ALPHA; RNA POLYMERASE II; TATA BINDING PROTEIN; THREONINE; CELL RECEPTOR; PHENOBARBITAL; TRANSCRIPTION FACTOR; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYP2B GENE; CYP2B10 GENE; CYP2B6 GENE; CYP2C55 GENE; CYTOPLASM; DNA SEQUENCE; ENZYME INACTIVATION; GENE; GENE EXPRESSION; GENE INACTIVATION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALE; MOUSE; MUTANT; NONHUMAN; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; WILD TYPE; ANIMAL; C3H MOUSE; CELL LINE; DRUG EFFECTS; LIVER; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CELL LINE; CELL NUCLEUS; HEPATOCYTES; LIVER; MICE; MICE, INBRED C3H; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOBARBITAL; PHOSPHORYLATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THREONINE; TRANSCRIPTION FACTORS;

EID: 85011382703     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.115.070235err     Document Type: Erratum

References (39)

1. Alepuz PM, de Nadal E, Zapater M, Ammerer G, and Posas F (2003) Osmostress-induced transcription by Hot1 depends on a Hog1-mediated recruitment of the RNA Pol II. EMBO J 22: 2433-2442.
2. Antoon JW, Bratton MR, Guillot LM, Wadsworth S, Salvo VA, and Burow ME (2012) Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation. Cancer Biol Ther 13:1026-1033.
3. Benet M, Lahoz A, Guzmán C, Castell JV, and Jover R (2010) CCAAT/enhancer-binding protein alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) synergistically cooperate with constitutive androstane receptor to transactivate the human cytochrome P450 2B6 (CYP2B6) gene: Application to the development of a metabolically competent human hepatic cell model. J Biol Chem 285:28457-28471.
4. Fernandez-Marcos PJ and Auwerx J (2011) Regulation of PGC-1a, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr 93:884S-890S.
5. Ferreiro I, Barragan M, Gubern A, Ballestar E, Joaquin M, and Posas F (2010) The p38 SAPK is recruited to chromatin via its interaction with transcription factors. J Biol Chem 285: 31819-31828.
6. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, and Saklatvala J (1994) Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78:1039-1049.
7. Gineste R, Sirvent A, Paumelle R, Helleboid S, Aquilina A, Darteil R, Hum DW, Fruchart JC, and Staels B (2008) Phosphorylation of farnesoid X receptor by protein kinase C promotes its transcriptional activity. Mol Endocrinol 22:2433-2447.
8. Gotoh S and Negishi M (2015) Statin-Activated nuclear receptor PXR promotes SGK2 dephosphorylation by scaffolding PP2C to induce hepatic gluconeogenesis. Sci Rep 5:14076.
9. Guo H, Gao C, Mi Z, Zhang J, and Kuo PC (2007) Characterization of the PC4 binding domain and its interactions with HNF4alpha. J Biochem 141:635-640.
10. Han J, Lee JD, Bibbs L, and Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
11. Hong YH, Varanasi US, Yang W, and Leff T (2003) AMP-Activated protein kinase regulates HNF4alpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 278:27495-27501.
12. Honkakoski P, Moore R, Gynther J, and Negishi M (1996) Characterization of phenobarbital-inducible mouse Cyp2b10 gene transcription in primary hepatocytes. J Biol Chem 271:9746-9753.
13. Honkakoski P, Zelko I, Sueyoshi T, and Negishi M (1998) The nuclear orphan receptor CARretinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18:5652-5658.
14. Hsieh JC, Jurutka PW, Nakajima S, Galligan MA, Haussler CA, Shimizu Y, Shimizu N, Whitfield GK, and Haussler MR (1993) Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site. J Biol Chem 268:15118-15126.
15. Huot J, Houle F, Marceau F, and Landry J (1997) Oxidative stress-induced actin reorganization mediated by the p38 mitogen-Activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80:383-392.
16. Inoue K and Negishi M (2008) Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P450 2B6 gene. J Biol Chem 283:10425-10432.
17. Inoue K and Negishi M (2009) Early growth response 1 loops the CYP2B6 promoter for synergistic activation by the distal and proximal nuclear receptors CAR and HNF4alpha. FEBS Lett 583:2126-2130.
18. Knutti D, Kressler D, and Kralli A (2001) Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc Natl Acad Sci USA 98:9713-9718.
19. Kobayashi K, Hashimoto M, Honkakoski P, and Negishi M (2015) Regulation of gene expression by CAR: An update. Arch Toxicol 89:1045-1055.
20. Konno Y, Kamino H, Moore R, Lih F, Tomer KB, Zeldin DC, Goldstein JA, and Negishi M (2010) The nuclear receptors constitutive active/androstane receptor and pregnane x receptor activate the Cyp2c55 gene in mouse liver. Drug Metab Dispos 38:1177-1182.
21. Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M, and Wang H (2008) The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol 74:443-453.
22. Lim CP, Jain N, and Cao X (1998) Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 16:2915-2926.
23. Mutoh S, Osabe M, Inoue K, Moore R, Pedersen L, Perera L, Rebolloso Y, Sueyoshi T, and Negishi M (2009) Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). J Biol Chem 284:34785-34792.
24. Mutoh S, Sobhany M, Moore R, Perera L, Pedersen L, Sueyoshi T, and Negishi M (2013) Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci Signal 6:ra31.
25. Osabe M and Negishi M (2011) Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm. J Biol Chem 286:35763-35769.
26. Picard N, Charbonneau C, Sanchez M, Licznar A, Busson M, Lazennec G, and Tremblay A (2008) Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-Associated protein ubiquitin ligase recruitment to the estrogen receptor beta. Mol Endocrinol 22:317-330.
27. Qiao L, MacDougald OA, and Shao J (2006) CCAAT/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-Activated protein kinase. J Biol Chem 281:24390-24397.
28. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, and Nebreda AR (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027-1037.
29. Saito K, Moore R, and Negishi M (2013a) Nuclear receptor CAR specifically activates the twopore K+ channel Kcnk1 gene in male mouse livers, which attenuates phenobarbital-induced hepatic hyperplasia. Toxicol Sci 132:151-161.
30. Saito K, Moore R, and Negishi M (2013b) p38 Mitogen-Activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene. Drug Metab Dispos 41:1170-1173.
31. Shao D and Lazar MA (1999) Modulating nuclear receptor function: may the phos be with you. J Clin Invest 103:1617-1618.
32. Shindo S, Moore R, Flake G, and Negishi M (2013) Serine 216 phosphorylation of estrogen receptor a in neutrophils: migration and infiltration into the mouse uterus. PLoS One 8:e84462.
33. Shiraki T, Sakai N, Kanaya E, and Jingami H (2003) Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-Activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state. J Biol Chem 278:11344-11350.
34. Sun K, Montana V, Chellappa K, Brelivet Y, Moras D, Maeda Y, Parpura V, Paschal BM, and Sladek FM (2007) Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization. Mol Endocrinol 21: 1297-1311.
35. Tremblay A, Tremblay GB, Labrie F, and Giguère V (1999) Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell 3:513-519.
36. Underwood DC, Osborn RR, Kotzer CJ, Adams JL, Lee JC, Webb EF, Carpenter DC, Bochnowicz S, Thomas HC, and Hay DW, et al. (2000) SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther 293:281-288.
37. Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, and Maronpot RR (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64:7197-7200.
38. Zhang L and Jope RS (1999) Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells. Neurobiol Aging 20:271-278.
39. Zhou W and Slingerland JM (2014) Links between oestrogen receptor activation and proteolysis: Relevance to hormone-regulated cancer therapy. Nat Rev Cancer 14:26-38.